VOR רווח למניה בשנים עשר החודשים האחרונים Vor Biopharma Inc.
Vor Biopharma Inc. (VOR) complies with basic environmental standards for biolaboratories. Ownership of unique cellular technology will ensure global distribution with low per-dose production costs. Rolling year earnings per share demonstrate capital efficiency, with the indicator value standing at 36.43. Innovations at the intersection of gene editing and various tumor therapies minimize clinical risks, as reflected by the price action on this chart.
פילוחים אנליטיים ודוחות נתונים של חברת Vor Biopharma, Inc. (VOR)
Net income per share over twelve months measures the actual specific profitability of the business, stripping the final financial result of the influence of the total number of securities. By analyzing the rolling annual earnings per share, an investor assesses the monetization efficiency of Vor Biopharma Inc. (VOR) unique cell therapy methods, where profit depends not on sales volume, but on the pricing power applied to complex individualized procedures.
